Brief: Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-Mediated Diseases

Ventyx Biosciences

07/01/2026 22:17

Jan 8 (Reuters) - Ventyx Biosciences Inc VTYX.O:

LILLY TO ACQUIRE VENTYX BIOSCIENCES TO ADVANCE ORAL THERAPIES TARGETING INFLAMMATORY-MEDIATED DISEASES

VENTYX BIOSCIENCES INC - LILLY WILL ACQUIRE ALL OF OUTSTANDING SHARES OF VENTYX FOR $14.00 PER SHARE

VENTYX BIOSCIENCES INC - PROPOSED DEAL FOR EQUITY VALUE OF APPROXIMATELY $1.2 BILLION

VENTYX BIOSCIENCES INC - TRANSACTION EXPECTED TO CLOSE IN FIRST HALF OF 2026

Source text: ID:nPn8nmGTVa

Further company coverage: VTYX.O

 ((Reuters.Briefs@thomsonreuters.com;))